Eugene Lowry

Eugene Lowry practices at Alameda Eye Physicians in Alameda, California.

Eugene Lowry's NPI, 1518384684, was assigned on March 26, 2014. Eugene Lowry graduated from UCSF School of Medicine in 2014. Eugene Lowry's California license number on file is A139751.

Eugene Lowry's primary practice is Alameda Eye Physicians, at 2241 Central Ave, Alameda, CA 94501. The practice phone is (510) 522-0377.

Eugene Lowry's primary practice is Alameda Eye Physicians in Alameda, California. Eugene Lowry is also affiliated with Alta Bates Summit Medical Center | Alta Bates Campus. The medical group on file is Alameda Health System. Dmand AI also links Eugene Lowry to 1 more hospital, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Eugene Lowry practices, 4 sites in all. Vendor and product names are available with a free account.

Glaucoma specialist is Eugene Lowry's primary specialty in the NPI Registry, under taxonomy code 207WX0009X. Eugene Lowry is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Eugene Lowry's licenses on file in 2 states: California and Oregon.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eyelid inflammation and glaucoma among the conditions Eugene Lowry treats.

CMS data shows 2,001 Medicare services from Eugene Lowry across 18 procedure codes in 2024, for 542 Medicare patients. Medicare paid $193,351 for them.

CMS counts 542 Medicare patients who saw Eugene Lowry in 2024. The largest group is 65 to 74, with 260 patients. 72% of them have high blood pressure, and 70% have high cholesterol. 55% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Eugene Lowry's median patient age at 71, with 53% women.

In 2024, Eugene Lowry wrote 2,174 Medicare Part D claims for 360 patients. 52% of them were for generic drugs. CMS names the drug for 2,107 of them, across 24 drugs with 11 or more claims each, at $195,683 in total drug cost. In 2023, CMS named 1,932 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Eugene Lowry for performance year 2024, reported as part of a group. Eugene Lowry accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 124 procedures of cataract surgery by Eugene Lowry, more than 77% of the clinicians it reports for that procedure.

Dmand AI links 24 papers to Eugene Lowry, published from 2013 to 2020. 2013 was the busiest year, with 2. The most frequent topics are Intraocular Pressure, Glaucoma and Ophthalmology. Eugene Lowry has published most often in J Glaucoma. Eugene Lowry's most frequent co-authors are Alejandra Gabriela De Alba Campomanes, MD, MPH, Steven L. Mansberger, MD, MPH and Ayman Naseri, MD.

CMS Open Payments shows 32 general payments to Eugene Lowry from 13 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Alcon Laboratories Inc paid the most, $194.

Eugene Lowry graduated from UCSF School of Medicine in 2014.

Eugene Lowry is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.